Protagenic Therapeutics, Inc.\new Quarterly Marketable Securities, Current in USD from Q3 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Protagenic Therapeutics, Inc.\new quarterly Marketable Securities, Current history and growth rate from Q3 2021 to Q1 2024.
  • Protagenic Therapeutics, Inc.\new Marketable Securities, Current for the quarter ending March 31, 2024 was $1.59M, a 78.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.59M -$5.92M -78.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.77M -$5M -64.3% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $5.12M -$2.88M -36% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $5.82M -$2.71M -31.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.51M -$1.79M -19.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $7.76M -$2.07M -21% Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 $7.99M -$2.4M -23.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $8.53M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $9.3M Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $9.83M Dec 31, 2021 10-K 2023-03-31
Q3 2021 $10.4M Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.